Skip to content
OpenCapital
Get started

Myriad Genetics MYGN Business Segments

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue by Geography
RoW$55.6M-1.6%$56.5M-3.1%$58.3M-5.4%$61.6M-2.8%$63.4M-6.9%
U.S.$773.4M+0.7%$768M+0.1%$767M-0.6%$771.3M+0.4%$767.9M-0.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Myriad Genetics break its business down?
Myriad Genetics (MYGN) reports revenue by product across 5 parts — Cancer Care Continuum, Hereditary Cancer, Mental Health, Prenatal Health and Prenatal. Each is extracted from the segment footnotes and tracked over time.
Where does Myriad Genetics's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Myriad Genetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.